Executive Summary
Overnight SEC filings reveal a surge in material definitive agreements, financings, and equity issuances across small-cap and micro-cap firms, signaling aggressive capital raising amid potential liquidity constraints, while routine Regulation FD disclosures dominate commodity ETFs with neutral impact. Biotech and pharma sectors show distress with bankruptcy, delisting notices, impairments, and agreement terminations, contrasting with neutral M&A activity in energy and infrastructure. Overall market impact is muted pre-open, but cumulative small-cap dilution risks and biotech failures warrant caution for portfolios exposed to high-beta names.
Tracking the trend? Catch up on the prior US Pre-Market SEC Filings Roundup digest from December 22, 2025.
Investment Signals(5)
- ▲
Multiple completions of acquisitions/dispositions indicating strategic expansion [BULLISH] - Repare Therapeutics, Loar Holdings, Acura Pharmaceuticals, New ERA Energy
- ▲
Frequent entry into material agreements with liquidity access via credit facilities [BULLISH] - loanDepot, Bausch Health, Target Hospitality
- ▲
Delisting notice signaling severe compliance failure [BEARISH] - DYADIC INTERNATIONAL
- ▲
Bankruptcy filing confirming insolvency [BEARISH] - Clearside Biomedical
- ▲
Terminations of key agreements disrupting pipelines [BEARISH] - Vaxart, Future Vision II Acquisition
Risk Flags(4)
- ▼
Cluster of biotech distress events (bankruptcy, delisting, impairments, terminations) risks sector contagion and portfolio drawdowns
- ▼
Widespread unregistered equity sales (Item 3.02) across 10+ filings heighten dilution risks for small-cap shareholders
- ▼
Undisclosed financial obligations (Item 2.03) in 8+ filings create hidden leverage buildup without quantified terms
- ▼
Management churn (Item 5.02) in multiple firms signals potential governance instability
Opportunities(4)
- ◆
Strategic acquisitions in pharma/energy provide turnaround catalysts for undervalued assets post-deal digestion
- ◆
Fresh credit facilities and financings in infrastructure/finance (e.g., HA Sustainable, Alexanders) offer liquidity-driven upside
- ◆
Commodity ETF Reg FD updates may precede price moves tied to energy macros
- ◆
Post-distress biotech names (e.g., post-bankruptcy restructurings) for contrarian long/short alpha
Sector Themes(3)
- Biotech/Pharma◆
Elevated distress with 6+ bearish events (bankruptcy, delisting, impairments) amid funding challenges
- Energy/Commodities◆
Routine neutral disclosures from 10+ funds suggest stable positioning ahead of market open
- Small-Cap Financings◆
Pervasive M&A, debt/equity raises (20+ filings) indicate sector-wide capital scramble for growth/defense
Watch List(4)
- 👁
Clearside Biomedical - Bankruptcy proceedings could trigger creditor actions and peer selloffs
- 👁
DYADIC INTERNATIONAL - Delisting risk erodes liquidity; monitor trading halt
- 👁
Vaxart & Future Vision II - Agreement terminations may signal failed deals; watch for alternatives or further cuts
- 👁
Biotech cluster (Omeros, Tonix, Inovio) - Cumulative Reg FD/Other Events for pipeline or funding updates
Filing Analyses(72)
29-12-2025
United States Gasoline Fund, LP filed a Form 8-K on December 29, 2025, disclosing Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. Accession Number: 0001104659-25-124474, file size 206 KB. Sector not specified.
29-12-2025
United States 12 Month Natural Gas Fund, LP filed an 8-K on December 29, 2025 (AccNo: 0001104659-25-124476, Size: 207 KB), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the disclosed information, events, transactions, or financial metrics provided in the summary. Sector not specified.
29-12-2025
Sidus Space Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001493152-25-029229, Size: 983 KB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no further details provided on the nature of the agreement, events, or exhibits. Sector not specified.
29-12-2025
United States 12 Month Oil Fund, LP filed a Form 8-K on December 29, 2025 (AccNo: 0001104659-25-124472, Size: 207 KB), disclosing Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event, transaction details, financial metrics, or numerical values are specified in the filing summary. Sector is not specified.
29-12-2025
CompoSecure, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001104659-25-124322, Size: 199 KB), reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on the matters voted upon, voting results, or any numerical data are explicitly stated in the provided filing information. This appears to be a routine disclosure of shareholder meeting outcomes.
29-12-2025
The registrant filed a Form 8-K on December 29, 2025 (AccNo: 0001654954-25-014312, Size: 150 KB), reporting under Item 2.03 the creation of a direct financial obligation or off-balance sheet arrangement via a Credit Agreement, and under Item 9.01 financial statements and exhibits. Event date is December 29, 2025. No specific dollar values, terms, counterparties, or other quantitative details are disclosed in the provided filing excerpt.
29-12-2025
New ERA Energy & Digital, Inc. filed an 8-K on December 29, 2025 (AccNo: 0001213900-25-125498, Size: 336 KB), disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.01 completion of an acquisition or disposition of assets. Item 9.01 includes financial statements and exhibits. No specific details on parties, deal structure, valuation, or terms are provided in the filing summary.
29-12-2025
Omeros Corp filed a Form 8-K on December 29, 2025 (AccNo: 0001437749-25-038758, size 228 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.
29-12-2025
Trio Petroleum Corp filed a Form 8-K on December 29, 2025 (AccNo: 0001493152-25-029158, size 273 KB), reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), and financial statements and exhibits (Item 9.01). This is a multi-item filing classified as a Material Event from US SEC source. No details on transaction value, parties, financial impact, or sector are disclosed.
29-12-2025
Dyadic International Inc filed an 8-K on December 29, 2025 (AccNo: 0001493152-25-029141, Size: 226 KB) under Item 3.01, disclosing a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No additional details on the core event, financial impacts, transaction values, or reasons for delisting are provided. Sector is not specified.
29-12-2025
Portland General Electric Co /OR/ filed an 8-K on December 29, 2025, under Item 8.01 Other Events (AccNo: 0000784977-25-000181, Size: 147 KB). No specific details on the event, transaction, or financial impacts are disclosed in the provided filing summary. Sector not specified.
29-12-2025
Vaxart, Inc. filed an 8-K on December 29, 2025 (AccNo: 0001437749-25-038774, Size: 155 KB) disclosing under Item 1.02 the termination of a material definitive agreement. No details on the agreement's parties, value, strategic role, or financial impacts are provided. Sector not specified.
29-12-2025
NextTrip, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001493152-25-029151, Size: 58 MB), reporting multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on transaction values, parties involved, financial impacts, or quantitative metrics are disclosed in the provided filing summary. This is a multi-item mandatory filing as a material event.
29-12-2025
HA Sustainable Infrastructure Capital, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001193125-25-332058, Size: 226 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.
29-12-2025
Brand Engagement Network Inc. filed a Form 8-K on 2025-12-29 (AccNo: 0001493152-25-029157, Size: 222 KB) reporting under Item 1.01 Entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. This is a multi-item filing for a material event. Sector not specified.
29-12-2025
Company filed Form 8-K on 2025-12-29 (AccNo: 0001104659-25-124353, Size: 2 MB) reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Off-Balance Sheet Arrangement), and Item 9.01 (Financial Statements and Exhibits). Event dated December 29, 2025. No specific transaction details, amounts, parties, or financial metrics disclosed in provided filing summary.
29-12-2025
ImmunityBio, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001193125-25-331244, Size: 188 KB) reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement, events, or financials provided in the summary. Sector not specified.
29-12-2025
loanDepot, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001831631-25-000264, Size: 2 MB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, and Item 9.01 Financial Statements and Exhibits. This is a multi-item mandatory disclosure of a material event, but specific details of the agreement, obligation, dollar value, or other terms are NOT_DISCLOSED in the provided summary. Sector is not specified.
29-12-2025
News Corp filed an 8-K on December 29, 2025 (AccNo: 0001564708-25-000609, size 400 KB), reporting Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or the financial statements/exhibits are disclosed in the provided filing summary. Sector not specified.
29-12-2025
Eve Holding, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001554855-25-002333, Size: 750 KB), disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No transaction details, dollar values, counterparties, or other specifics are stated in the provided filing summary.
29-12-2025
Clearside Biomedical, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001193125-25-332152, Size: 3 MB), reporting bankruptcy or receivership under Item 1.03, other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the bankruptcy proceedings, financial impacts, or transaction values are disclosed in the provided filing summary. Sector not specified.
29-12-2025
Repare Therapeutics Inc. filed an 8-K on December 29, 2025 (AccNo: 0001193125-25-332236, Size: 624 KB), disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). Additional disclosures include Regulation FD Disclosure (Item 7.01), Other Events (Item 8.01), and Financial Statements and Exhibits (Item 9.01). No specific details on parties, deal structure, valuation, or terms are provided.
29-12-2025
Intel Corp filed a Form 8-K on December 29, 2025 (AccNo: 0000050863-25-000204), reporting under Item 3.02 regarding Unregistered Sales of Equity Securities. No specific details on transaction value, share count, parties, or financial impact are disclosed in the provided filing information. This appears to be a single-item mandatory disclosure.
29-12-2025
Orion Group Holdings Inc filed a Form 8-K on December 29, 2025 (AccNo: 0001402829-25-000065), reporting entry into a material definitive agreement (Item 1.01), termination of a material definitive agreement (Item 1.02), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), material modifications to rights of security holders (Item 3.03), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). This is a multi-item filing with no specific transaction details, dollar values, parties, or quantitative impacts disclosed in the provided information.
29-12-2025
Future Vision II Acquisition Corp. filed an 8-K on December 29, 2025 (AccNo: 0001829126-25-010308, Size: 274 KB), disclosing under Item 1.02 the termination of a material definitive agreement. Item 9.01 includes financial statements and exhibits. No details on parties, deal structure, valuation, or reasons for termination are provided.
29-12-2025
Undisclosed company filed an 8-K on December 29, 2025 (AccNo: 0001628280-25-058806, Size: 86 MB) reporting under Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), 3.02 (Unregistered Sales of Equity Securities), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure of a material event, filed on the event date, likely within the required 4-business-day window. No specific details on transaction value, parties, financial impacts, or strategic context are provided.
29-12-2025
Sable Offshore Corp. filed a Form 8-K on December 29, 2025, under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). Accession Number: 0001831481-25-000146; file size: 192 KB. No specific details on the disclosure content, events, transactions, or financial data are provided.
29-12-2025
Vocodia Holdings Corp filed a Form 8-K on December 29, 2025 (AccNo: 0001493152-25-029168, Size: 190 KB) disclosing an officer change under Item 5.02. Item 5.02 covers Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Sector not specified; no specific details on positions, individuals, or reasons provided.
29-12-2025
Crown Equity Holdings, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001477932-25-009191, Size: 131 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or compensation are provided. Sector is not specified.
29-12-2025
TILE SHOP HOLDINGS, INC. filed a Form 8-K on December 29, 2025 (AccNo: 0001140361-25-046671, Size: 153 KB) reporting under Item 8.01 Other Events. No details on the specific event, transaction, or financial impacts are disclosed in the provided filing summary. Sector not specified.
29-12-2025
Bolt Projects Holdings, Inc. filed a Form 8-K on December 29, 2025, reporting under Item 7.01 Regulation FD Disclosure. Accession Number: 0001841125-25-000166, file size 221 KB. No specific details on the disclosure content, events, transactions, or financial impacts are provided.
29-12-2025
Volato Group, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001628280-25-058838, Size: 145 KB) disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. Item 9.01 references financial statements and exhibits. No specific details on the affected officer, position, reason, or compensation are provided.
29-12-2025
Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001493152-25-029162, size 219 KB), disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are provided in the filing summary. Sector not specified.
29-12-2025
Target Hospitality Corp. filed a Form 8-K on December 29, 2025 (AccNo: 0001104659-25-124455, size 1 MB), reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. This is a multi-item filing disclosing a core material event without specific details on the agreement, transaction value, or exhibits provided in the available summary. Sector not specified.
29-12-2025
Loar Holdings Inc. filed an 8-K on December 29, 2025 (AccNo: 0001193125-25-332267), disclosing entry into a material definitive agreement (Item 1.01), completion of acquisition or disposition of assets (Item 2.01), creation of a direct financial obligation (Item 2.03), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). Specific details on deal structure, parties, valuation, synergies, or impacts are NOT_DISCLOSED. Sector is not specified.
29-12-2025
Glucotrack, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001493152-25-029216, Size: 11 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure with no specific core event, transaction details, financial metrics, or quantitative data provided in the filing summary. Sector is not specified.
29-12-2025
Bausch Health Companies Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0000885590-25-000059, Size: 264 KB), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. Item 9.01 discloses financial statements and exhibits. No specific transaction details, values, parties, or other quantitative data are provided in the filing summary.
29-12-2025
United States Commodity Index Funds Trust filed a Form 8-K on December 29, 2025 (AccNo: 0001104659-25-124478, size 287 KB), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the disclosures, events, transactions, or financial data are provided in the filing summary. Sector not specified.
29-12-2025
United States Brent Oil Fund, LP filed a Form 8-K on December 29, 2025, reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. Accession number 0001104659-25-124477, file size 206 KB. Sector not specified; no transaction details, financial metrics, or other specifics disclosed in the provided filing summary.
29-12-2025
United States Oil Fund, LP filed a Form 8-K on December 29, 2025 (AccNo: 0001104659-25-124469, size 210 KB), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event, transaction details, financial metrics, or quantitative data are explicitly stated in the provided filing summary. This appears to be a multi-item voluntary disclosure typical for Regulation FD updates with attached exhibits.
29-12-2025
United States Natural Gas Fund, LP filed an 8-K on December 29, 2025 (AccNo: 0001104659-25-124471, Size: 207 KB) reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No core event, transaction details, financial metrics, or quantitative data are disclosed in the filing summary. This appears to be a voluntary disclosure of material information with attached exhibits.
29-12-2025
Tonix Pharmaceuticals Holding Corp. filed a Form 8-K on December 29, 2025 (AccNo: 0001999371-25-021194, Size: 270 KB), reporting Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the core events, transactions, or financial impacts provided in the summary. Sector not specified.
29-12-2025
Acura Pharmaceuticals, Inc. filed an 8-K on December 29, 2025 (AccNo: 0001104659-25-124500, Size: 294 KB), disclosing under Item 1.01 entry into a material definitive agreement, Item 2.01 completion of an acquisition or disposition of assets, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and Item 9.01 financial statements and exhibits. No details on deal structure, parties, valuation, consideration, or strategic rationale are provided in the filing summary. Sector is not specified.
29-12-2025
News Corp filed a Form 8-K on December 29, 2025 (AccNo: 0001564708-25-000610, Size: 557 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.
29-12-2025
Praxis Precision Medicines, Inc. filed a Form 8-K on December 29, 2025, reporting under Item 8.01 Other Events. The filing has Accession Number 0001689548-25-000118 and size of 145 KB. No specific details on the event, transaction, or financial impacts are disclosed in the provided information.
29-12-2025
Cerence Inc. filed a Form 8-K on December 29, 2025, reporting under Item 8.01 Other Events. Accession number: 0001628280-25-058847; file size: 140 KB. Sector not specified; no further details on the event provided in the available information.
29-12-2025
Mount Logan Capital Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0002051820-25-000176, Size: 162 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 8.01 (Other Events). No specific details on the core events, transactions, financial impacts, or quantitative data are disclosed in the provided filing summary. This is a multi-item voluntary disclosure with no mentioned dollar values, share counts, or other metrics.
29-12-2025
BGC Group, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001628280-25-058853, Size: 232 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No core event details, transaction values, financial metrics, or other quantitative data are disclosed in the provided filing summary. This appears to be a voluntary disclosure of potentially material nonpublic information via Regulation FD, with exhibits attached.
29-12-2025
TGE Value Creative Solutions Corp filed a Form 8-K on December 29, 2025 (AccNo: 0001213900-25-125808, Size: 2 MB), reporting multiple items: Entry into a Material Definitive Agreement (Item 1.01), Unregistered Sales of Equity Securities (Item 3.02), Amendments to Articles of Incorporation or Bylaws/Change in Fiscal Year (Item 5.03), Other Events (Item 8.01), and Financial Statements and Exhibits (Item 9.01). This is a multi-item mandatory filing for specified events, but specific details on the core transaction, dollar values, share counts, or financial impacts are NOT_DISCLOSED in the provided information. Sector is not specified.
29-12-2025
Twin Hospitality Group Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001493152-25-029211, Size: 234 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, appointment/resignation status, reasons, or any quantitative data provided in the filing summary. Sector not specified.
29-12-2025
Theriva Biologics, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001104659-25-124523, Size: 233 KB), reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the core event, transaction, financial impacts, or quantitative data are disclosed in the provided filing summary. This is a multi-item voluntary or mandatory disclosure depending on the underlying events, filed from US SEC source.
29-12-2025
My Size, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001493152-25-029213, Size: 232 KB), disclosing under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results. No specific financial metrics, transaction values, or other quantitative details are provided in the filing summary.
29-12-2025
AMERICAN ELECTRIC POWER CO INC filed a Form 8-K on December 29, 2025 (AccNo: 0000004904-25-000202, Size: 334 KB), reporting under Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year) and Item 9.01 (Financial Statements and Exhibits). No specific details on the amendments, fiscal year change, or exhibits are disclosed in the provided filing summary. Sector not specified.
29-12-2025
Mount Logan Capital Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0002051820-25-000178, size 186 KB) reporting under Item 8.01 Other Events. No details on the specific event, transaction, financial impacts, or other quantitative data are disclosed in the provided filing summary. Sector is not specified.
29-12-2025
ALEXANDERS INC filed an 8-K on December 29, 2025 (AccNo: 0000003499-25-000038, Size: 186 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), with Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, transaction value, terms, or financial metrics are provided in the summary. Sector not specified.
29-12-2025
INOVIO PHARMACEUTICALS, INC. filed a Form 8-K on December 29, 2025 (AccNo: 0001193125-25-3323322, Size: 164 KB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure as Items 7.01 and 8.01 are typically voluntary. No core event details, transaction values, financial metrics, or other specifics are disclosed in the provided filing summary.
29-12-2025
ImmuCell Corporation (/DE/) filed a Form 8-K on December 29, 2025 (AccNo: 0001437749-25-038773, size 190 KB), reporting under Item 2.06 Material Impairments, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This is a multi-item mandatory filing disclosing material impairments and other events, but specific details on the core event, dollar values, financial impacts, or transaction sizes are NOT_DISCLOSED in the provided summary. No quantitative financial metrics, named entities beyond the filer, or additional context are available.
29-12-2025
Luminar Technologies, Inc./DE filed a Form 8-K on December 29, 2025 (AccNo: 0001140361-25-046697, size: 156 KB), disclosing under Item 2.05 costs associated with exit or disposal activities. Sector is not specified. No specific dollar values, transaction details, or other quantitative data are mentioned.
29-12-2025
Strategy Inc filed a Form 8-K on December 29, 2025 (AccNo: 0001193125-25-332296, Size: 374 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 8.01 Other Events. No specific details on the core event, transaction, financial impacts, or quantitative metrics are disclosed in the provided filing summary. All transaction values, share counts, percentages, and financial metrics are NOT_DISCLOSED.
29-12-2025
Compass Diversified Holdings filed a Form 8-K on December 29, 2025 (AccNo: 0001345126-25-000093), reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. This is a financial results disclosure for the US market. No specific financial metrics, transaction values, or other quantitative details are disclosed in the provided filing summary.
29-12-2025
DigitalBridge Group, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001104659-25-124541, Size: 312 KB), disclosing Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event, transaction details, financial metrics, or quantitative data are specified in the filing summary. This appears to be a voluntary disclosure of material nonpublic information with attached exhibits.
29-12-2025
Peoples Financial Services Corp. filed a Form 8-K on December 29, 2025, under Item 8.01 Other Events. The filing has accession number 0001104659-25-124540 and size of 194 KB. No details on the specific event, transaction, or financial impacts are disclosed in the provided filing summary.
29-12-2025
QHSLab, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001493152-25-029222, Size: 439 KB), reporting Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction details, dollar values, share counts, or financial metrics disclosed in the provided summary. Sector is not specified.
29-12-2025
Tron Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001493152-25-029225, Size: 309 KB), reporting multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, sales, transaction value, parties, or financial impacts disclosed in the provided summary. Sector not specified.
29-12-2025
Adicet Bio, Inc. filed a Form 8-K on December 29, 2025 (AccNo: 0001193125-25-332343, Size: 232 KB), reporting under Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary or mandatory disclosure depending on specifics not detailed here, with no transaction values, financial metrics, or other numerical data provided in the filing summary. Analysis is constrained by absence of filing content details.
29-12-2025
Exact Sciences Corp filed an 8-K on December 29, 2025 (AccNo: 0001193125-25-332352, Size: 194 KB) disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals, reasons, or quantitative data are provided.
29-12-2025
Ultragenyx Pharmaceutical Inc. filed a Form 8-K on December 29, 2025, under Item 8.01 Other Events. The filing has Accession Number 0001193125-25-332422 and is 157 KB in size. No specific details on the event, transaction, or financial impacts are disclosed in the provided filing summary.
29-12-2025
Copper Property CTL Pass Through Trust filed an 8-K on December 29, 2025 (AccNo: 0001837671-25-000091, Size: 136 KB) reporting under Item 8.01 Other Events. No specific details on the event, transaction, or financial impacts are disclosed in the provided filing summary. Sector is not specified.
29-12-2025
Eightco Holdings Inc. filed a Form 8-K on December 29, 2025, reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details, transactions, financial metrics, or quantitative data are disclosed in the provided filing summary. This is a multi-item voluntary disclosure filing with no core event or impact described.
29-12-2025
BITMINE IMMERSION TECHNOLOGIES, INC. filed a General Filing (likely Form 8-K) on December 29, 2025, under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). Accession Number: 0001493152-25-029227; File Size: 10 MB. No specific details on events, transactions, financials, or exhibits are disclosed in the provided filing summary.
29-12-2025
Fidelity D & D Bancorp Inc filed a Form 8-K on December 29, 2025 (AccNo: 0001437749-25-038783, Size: 252 KB), disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or quantitative data are provided in the filing summary.
Get daily alerts with 5 investment signals, 4 risk alerts, 4 opportunities and full AI analysis of all 72 filings
🇺🇸 More from United States
View all →March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC
March 24, 2026
US Corporate Distress Financial Stress SEC Filings — March 24, 2026
US Corporate Distress Financial Stress SEC Filings